Intrinsic Value

Myriad Genetics, Inc. (MYGN)

$18.5

-0.01 (-0.05%)

Enterprise Value -2,496.67
Net Debt 88.10
Equity Value -2,584.77
Shares Outstanding 80.60
Equity Value Per Share -32.07



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt